Breaking News
Lessons from a canceled marathon: Athletic events, heat and the effects of climate change
Safety in and near the water: A pediatric emergency medicine physician offers tips
High cholesterol signs: The warning sign that can strike at night – may interrupt sleep
Scientists calm fears about new Langya virus in China
Study finds climate hazards can aggravate over half of known human infectious diseases
Health alert issued as vulnerable people set to suffer from bone-dry 97F heat
Arthritis: The 70p anticancer herb that may reverse painful inflammation in the joints
Skip to content
  • Health Problems
  • Personal Health
  • Family Health
  • Health News
  • Kids Health
  • Medications
  • Beauty & Balance

FLORESHEALTH

  • Health Problems
  • Personal Health
  • Family Health
  • Health News
  • Kids Health
  • Medications
  • Beauty & Balance

Home ยป (isatuximab-irfc)

FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

April 7, 2021Medications

PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…

(isatuximab-irfc), and, approves, Carfilzomib, combination, dexamethasone, FDA, for, in, multiple, myeloma, or, Patients, Refractory, Relapsed, Sarclisa, With
Recent Posts
  • Lessons from a canceled marathon: Athletic events, heat and the effects of climate change
  • Safety in and near the water: A pediatric emergency medicine physician offers tips
  • High cholesterol signs: The warning sign that can strike at night – may interrupt sleep
  • Scientists calm fears about new Langya virus in China
  • Study finds climate hazards can aggravate over half of known human infectious diseases
Copyright © All rights reserved.